DUOPHARMA BIOTECH BERHAD

DPHARMA showing short term sign of weakness

250
Bearish RSI divergence appeared. Might revisit trendline at fibo .236 level before rebounding higher. Possible low risk entry at trendline, buy on weakness.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。